185 related articles for article (PubMed ID: 8693268)
1. [Bronchial mucolytic agents].
Leuenberger P
Rev Med Suisse Romande; 1996 May; 116(5):335-9. PubMed ID: 8693268
[No Abstract] [Full Text] [Related]
2. [The use of expectorant agents].
Galsanov Shch B
Sov Med; 1987; (12):100-5. PubMed ID: 3328304
[No Abstract] [Full Text] [Related]
3. [Bronchial mucus modifiers, antioxidants and antiproteases].
Polu JM; Chabot F; Wallaert B
Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
[No Abstract] [Full Text] [Related]
4. Drug effects on viscoelasticity of mucus.
Puchelle E; Zahm JM; Polu JM; Sadoul P
Eur J Respir Dis Suppl; 1980; 110():195-208. PubMed ID: 6938383
[No Abstract] [Full Text] [Related]
5. [Liquifiers of bronchial secretion. (Value of viscosimetric tests)].
Molina C; Aiache JM
Sem Ther; 1968 Oct; 44(8):462-4. PubMed ID: 5740247
[No Abstract] [Full Text] [Related]
6. [Modifiers of bronchial secretions in the asthmatic patient].
Medici TC; Radielovic P
Allergol Immunopathol (Madr); 1981; Suppl 9():201-6. PubMed ID: 7349729
[No Abstract] [Full Text] [Related]
7. Evaluation of bronchodilators and mucolytic agents.
Kamat SR
J Postgrad Med; 1979 Jan; 25(1):1-3. PubMed ID: 458736
[No Abstract] [Full Text] [Related]
8. [Biochemical and enzymatic characteristics of bronchial secretions and their changes during treatment with mucolytic drugs].
Olivieri D; Bocchino M; Marzo C
Arch Monaldi; 1974; 29(3-4):283-308. PubMed ID: 4463914
[No Abstract] [Full Text] [Related]
9. [Experiences with the new mucolytic agent Bisolvon in general practice, with special reference to asthmoid states].
Stäubli C
Praxis; 1966 Jul; 55(30):850-3. PubMed ID: 5953646
[No Abstract] [Full Text] [Related]
10. Bronchial mucus secretion in cystic fibrosis.
Sturgess JM
Mod Probl Paediatr; 1976 Oct 24-27; 19():129-40. PubMed ID: 1031902
[No Abstract] [Full Text] [Related]
11. [Treatment of serous and puruloid bronchial hypersecretions in acute and chronic bronchopneumopathies: our experience with a new mucolytic drug].
Fossati C
Clin Ter; 1975 Jul; 74(1):63-82. PubMed ID: 770054
[No Abstract] [Full Text] [Related]
12. [Drug therapy of bronchosecretolytic disorders].
Schmidt OP
Med Klin; 1977 Feb; 72(5):145-60. PubMed ID: 321928
[No Abstract] [Full Text] [Related]
13. Mucus-controlling agents: past and present.
King M; Rubin BK
Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882
[TBL] [Abstract][Full Text] [Related]
14. [Expectorant and liquescent preparations in the therapy of bronchial asthma and nonspecific lung diseases and their prevention].
Komarov FI; Daniliak IG; Guliaeva FE; Mindlina GI; Zhukova AV
Klin Med (Mosk); 1980 Apr; 58(4):19-24. PubMed ID: 6991798
[No Abstract] [Full Text] [Related]
15. Bacterial flora of bronchial secretion.
Székely E; Farkas E
Acta Med Acad Sci Hung; 1968; 25(2):127-40. PubMed ID: 5728887
[No Abstract] [Full Text] [Related]
16. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
17. [Proteolytic enzymes and their inhibitors in bronchopulmonary diseases (a review of the literature)].
Veremeenko KN; Kizim AI
Vrach Delo; 1985 Jul; (7):34-8. PubMed ID: 3901514
[No Abstract] [Full Text] [Related]
18. [Round table. Relevant controls and usefulness of treatments modifying bronchial secretions (author's transl)].
Bull Physiopathol Respir (Nancy); 1973; 9(2):417-71. PubMed ID: 4778961
[No Abstract] [Full Text] [Related]
19. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
[TBL] [Abstract][Full Text] [Related]
20. Mucus and mucins.
Rubin BK
Otolaryngol Clin North Am; 2010 Feb; 43(1):27-34, vii-viii. PubMed ID: 20172254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
